Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board

— Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce that it has added world renowned drug discovery expert Dr. Denton Hoyer to its Scientific Advisory Board. Dr. Hoyer has been involved in drug discovery at leading pharmaceutical companies and research institutions for the last 30 years. He holdsContinue reading “Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board”

Vireo Health Expands Maryland Operations with Purchase of 110,000 Sq. Ft. Greenhouse

– $1.3 million cash transaction expands Vireo’s Maryland cultivation capacity by nearly 12x – – Vireo to transfer cultivation license to new greenhouse; maintain existing processing facility – — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in nine statesContinue reading “Vireo Health Expands Maryland Operations with Purchase of 110,000 Sq. Ft. Greenhouse”